Aachen, Germany

Michael Pinkawa


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Pinkawa - Innovator in Radiotherapy Monitoring

Introduction

Michael Pinkawa is a notable inventor based in Aachen, Germany. He has made significant contributions to the field of radiotherapy through his innovative methods and devices. His work focuses on improving patient outcomes by enhancing the monitoring of side effects during treatment.

Latest Patents

Michael Pinkawa holds a patent for a "Method and device for side-effect prognosis and monitoring." This invention provides a method for radiotherapy monitoring that includes the calculation of treatment-guiding indices of side effects. The method is based on processing image-derived descriptors and measurement values of selected disease-specific biomarkers, and it may also incorporate questionnaire data. Additionally, a computer program product is included in this patent, showcasing the technological advancements in patient care.

Career Highlights

Michael Pinkawa is associated with Koninklijke Philips Corporation N.V., a leading company in health technology. His role at Philips allows him to work on cutting-edge innovations that aim to improve the quality of healthcare. His dedication to research and development has positioned him as a key figure in the field of medical technology.

Collaborations

Michael collaborates with talented professionals such as Carolina Ribbing and Martin Weibrecht. Their combined expertise contributes to the advancement of technologies that enhance patient care and treatment efficacy.

Conclusion

Michael Pinkawa's contributions to radiotherapy monitoring exemplify the impact of innovation in healthcare. His patent and work at Koninklijke Philips Corporation N.V. reflect a commitment to improving patient outcomes through advanced technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…